The University of Connecticut received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 15, 2025, with a completion date of August 14, 2027, supports research aimed at "Enhancing Inflammation-Repressive Function of the Lupus Susceptibility Protein TNIP1". This project-based grant contributes to the program's broader objective of transforming healthcare for military service members, veterans, and the public through innovative biomedical research. The University of Connecticut, a prominent 1862 land-grant institution, leverages its multidisciplinary expertise in areas such as biomedical research, engineering, and advanced technology development to support this scientific investigation, which has the potential to yield medical solutions relevant to the military.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $300.0k | 7/30/25 |